← Back to headlines
Kyverna Reports Positive Mid-Stage Trial Data for Myasthenia Gravis Therapy
Kyverna's stock rose following the release of new mid-stage trial data for its myasthenia gravis therapy.
20 Apr, 18:15 — 20 Apr, 18:15
Sources
Showing 1 of 1 sources
Related Stories
'Astronauts back on Earth': Artemis II crew splashes down after record-breaking moon flyby – video
just now
Ancient Underwater City Discovered Off Turkish Coast Reveals Advanced Urban Planning
26m ago
Poor Biosafety Practices Blamed for Foot-and-Mouth Disease Spread
28m ago
Artemis II Astronaut Captures First "Earthset" Video
43m ago